Get started
Author

Johanna Smeds

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 · Christos Sotiriou, Pratyaksha Wirapati, et al. · JNCI Journal of the National Cancer Institute · 2,029
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
2005 · Lance D. Miller, Johanna Smeds, et al. · Proceedings of the National Academy of Sciences · 1,240
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
2005 · Yudi Pawitan, Judith Bjöhle, et al. · Breast Cancer Research · 815
PDF
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
2006 · Anna V. Ivshina, Joshy George, et al. · Cancer Research · 734
PDF
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
2006 · Stefano Calza, Per Hall, et al. · Breast Cancer Research · 259
PDF
Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells and Correlations with Clinical Outcome
2006 · Jonna Frasor, Edmund C. Chang, et al. · Cancer Research · 163
PDF
Significant Impact of Promoter Hypermethylation and the 540 C>T Polymorphism of CDKN2A in Cutaneous Melanoma of the Vertical Growth Phase
2002 · Oddbjørn Straume, Johanna Smeds, et al. · American Journal Of Pathology · 105
PDF
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer
2007 · Chin-Yo Lin, Anders Ström, et al. · Breast Cancer Research · 102
PDF
A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare
2001 · Rajiv Kumar, Johanna Smeds, et al. · International Journal of Cancer · 95
PDF
Analysis of G1/S checkpoint regulators in metastatic melanoma
2000 · Ilari Sauroja, Johanna Smeds, et al. · Genes Chromosomes and Cancer · 83
Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus)
1999 · R. Kumar, J. Smeds, et al. · Melanoma Research · 79
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study
2006 · Per Hall, Alexander Ploner, et al. · BMC Medicine · 68
PDF
Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16INK4a and p14ARF ) and p53 genes are major targets for inactivation
2002 · J. Smeds · Carcinogenesis · 67
Low frequency of BRAF and CDKN2A mutations in endometrial cancer
2005 · Helga B. Salvesen, Rajiv Kumar, et al. · International Journal of Cancer · 45
Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome
2007 · J. Bergqvist, J.F. Ohd, et al. · Annals of Oncology · 39
PDF
Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes
2006 · Kristian Wennmalm, Stefano Calza, et al. · Genes Chromosomes and Cancer · 16
Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: Analysis of loss of heterozygosity
2005 · Johanna Smeds, Fredrik Wärnberg, et al. · Acta Oncologica · 15
PDF
Gene profile and response to treatment
2005 · J. Smeds, L.D. Miller, et al. · Annals of Oncology · 12
PDF
Better characterization of estrogen receptor (ER) positive luminal subtypes using genomic grade
2005 · Christos Sotiriou, Pratyaksha Wirapati, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 8
Polymorphic insertion of additional repeat within an area of direct 8 bp tandem repeats in the 5'-untranslated region of the p53R2 gene and cancer risk
2001 · J. Smeds · Mutagenesis · 8
Increased frequency of LOH on chromosome 9 in sporadic primary melanomas is associated with increased patient age at diagnosis
2000 · J. Smeds · Mutagenesis · 7
Molecular characterization of clinical grade in breast cancer (BC) challenges the existence of “grade 2” tumors
2005 · C. Sotiriou, P. Wirapati, et al. · Journal of Clinical Oncology · 5
A novel polymorphism (-88 C>A) in the 5? UTR of the p53R2 gene
2000 · Johanna Smeds, Mariachiara Nava, et al. · Human Mutation · 5
Better characterization of estrogen receptor (ER) positive luminal subtypes of breast cancer using genomic grade.
2005 · Christine Desmedt, Christos Sotiriou, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 4
Gene expression profiling in breast cancer challenges the existence of intermediate histological grade
2005 · C Sotiriou, P Wirapati, et al. · Breast Cancer Research · 3
PDF
Works count: 57
Citation count: 6,009
H-index: 16
I10-index: 18
Year
Topic
Type